Persistent Activation of CD8+ T-cells Characterizes Prediabetic Twins
暂无分享,去创建一个
[1] M. Hussain,et al. Increased Expression of T-Cell Markers of Immunological Memory Associated with Protection from Type I Diabetes: A study of Identical Twins , 1994, Diabetes.
[2] A. Beavis,et al. Tracking of murine spleen cells in vivo: detection of PKH26-labeled cells in the pancreas of non-obese diabetic (NOD) mice. , 1994, Journal of immunological methods.
[3] L. Harrison,et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes , 1993, The Lancet.
[4] O. Simell,et al. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.
[5] R. Leslie,et al. Antibodies to GAD and Tryptic Fragments of Islet 64K Antigen as Distinct Markers for Development of IDDM: Studies With Identical Twins , 1992, Diabetes.
[6] M. Erlander,et al. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes , 1992, The Lancet.
[7] R. Leslie,et al. Studies of diabetic twins. , 1991, Diabetes/metabolism reviews.
[8] S. Romagnani. Human TH1 and TH2 subsets: doubt no more. , 1991, Immunology today.
[9] S. Arden,et al. T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes , 1991, The Lancet.
[10] Bart O. Roep,et al. T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins , 1990, Nature.
[11] D. Vergani,et al. Effect of Initiation of Insulin Therapy on T‐lymphocyte Activation in Type 1 Diabetes , 1990, Diabetic medicine : a journal of the British Diabetic Association.
[12] E. Bonifacio,et al. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes , 1990, The Lancet.
[13] M. Feldmann,et al. DO CD4-POSITIVE CYTOTOXIC T CELLS DAMAGE ISLET β CELLS IN TYPE 1 DIABETES? , 1988, The Lancet.
[14] M. Feldmann,et al. The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+. , 1988, Clinical and experimental immunology.
[15] D. R. Gamble,et al. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. , 1985, The New England journal of medicine.
[16] A. Michael,et al. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. , 1985, Laboratory investigation; a journal of technical methods and pathology.
[17] Hoskins,et al. PATHOGENESIS OF INSULIN-DEPENDENT DIABETES: A ROLE FOR ACTIVATED T LYMPHOCYTES , 1984, The Lancet.
[18] P. Pozzilli,et al. Monoclonal Antibodies Defined Abnormalities of T-Lymphocytes in Type I (Insulin-dependent) Diabetes , 1983, Diabetes.
[19] B. Haynes,et al. Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. , 1982, The New England journal of medicine.
[20] Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.
[21] K. C. Tan,et al. T cell clones generated from patients with type 1 diabetes using interleukin-2 proliferate to human islet antigens. , 1994, Autoimmunity.
[22] M. Feldman,et al. Human islet cell induced T cell lines and clones from diabetic children. , 1991, Autoimmunity.
[23] G. Eisenbarth,et al. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. , 1990, Annual review of immunology.